Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ABO Hemolytic Disease of Newborn”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Looking for participantsNCT03214354
What this trial is testing

Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor

Who this might be right for
Sickle Cell DiseaseStem Cell Transplant ComplicationsRed Blood Cell Disorder+1 more
University of Calgary 12
Not applicableStudy completedNCT06502847
What this trial is testing

The Role of Breastmilk and Serum Exosomes in Neonatal Jaundice Due to ABO Incompatibility

Who this might be right for
Neonatal Jaundice From Other Specified CausesABO IncompatibilityABO Hemolytic Disease
Kanuni Sultan Suleyman Training and Research Hospital 338
Testing effectiveness (Phase 2)Study completedNCT03842189
What this trial is testing

Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Who this might be right for
Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC 25
Not applicableUnknownNCT06314789
What this trial is testing

The Use of Lung Ultrasonography in the Delivery Room in Neonates

Who this might be right for
Suspected Damage to Fetus From Other Disease in the Mother, Affecting Management of Mother, With DeliveryPatient Death or Serious Disability Associated With A Haemolytic Reaction Due to the Administration of ABO-Incompatible Blood or Blood Products
Kırıkkale University 112
Not applicableLooking for participantsNCT07110987
What this trial is testing

The Efficacy of Ursodeoxycholic Acid (UDCA) as Adjuvant Therapy to Phototherapy in the Management of Neonatal Indirect Hyperbilirubinemia

Who this might be right for
Hyperbilirubinemia, Neonatal Indirect
Tishreen University Hospital 70
Testing effectiveness (Phase 2)Study completedNCT01887327
What this trial is testing

Stannsoporfin With Light Therapy for Newborn Babies With Jaundice

Who this might be right for
Jaundice, NeonatalHyperbilirubinemia, Neonatal
InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company 91
Very early researchUnknownNCT03130517
What this trial is testing

Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease

Who this might be right for
Haemolysis Neonatal
Assiut University 30
Not applicableLooking for participantsNCT05842109
What this trial is testing

Clinical Value of ETCOc in the Diagnosis and Treatment of ABO-HDN

Who this might be right for
ABO Hemolytic Disease of Newborn
Women's Hospital School Of Medicine Zhejiang University 112
Not applicableWithdrawnNCT00917007
What this trial is testing

Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis

Who this might be right for
ABO IncompatibilityHemolytic Disease of NewbornNeonatal Jaundice+1 more
State University of New York - Upstate Medical University